Equities

Terveystalo Oyj

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Terveystalo Oyj

Actions
  • Price (EUR)10.18
  • Today's Change0.04 / 0.39%
  • Shares traded--
  • 1 Year change-13.73%
  • Beta0.3371
Data delayed at least 15 minutes, as of Feb 06 2026 15:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Terveystalo Oyj, formerly Terveystalo Oy, is a Finland-based private healthcare service provider. It offers healthcare services to corporate, private and public sector customers. Its healthcare service offering includes general practice and specialist medical care, diagnostic services, outpatient surgery, dental services and other adjacent services, which together comprise its integrated healthcare care chain. It also offers a suite of digital healthcare services. It is able to provide nationwide reach through its approximately 180 clinics, covering Finland's largest cities, together with its digital platforms. The Company’s customers are divided into the following groups: Corporate Customers, who the Company partners with to provide, for example, occupational healthcare services to their employees, as well as Private Customers and Public Customers, who the Company partners with to provide public healthcare services and occupational healthcare services to municipal employees.

  • Revenue in EUR (TTM)1.30bn
  • Net income in EUR90.80m
  • Incorporated2013
  • Employees5.58k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
TTALO:HEX since
announced
Transaction
value
Veikkolan Hammaslaakariasema OyDeal completed02 May 202502 May 2025Deal completed-15.52%--
Data delayed at least 15 minutes, as of Feb 06 2026 17:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.